// App-Quantinova.ai

4684 : Modulating the function of multidrug resistance ABCG2 transporter by tyrosine kinases receptor inhibitor cabozantinib

Researchers

Presenter

  • Guannan Zhang

Principal Investigators

  • Yun-Kai Zhang

  • Yi-Jun Wang

  • Zhe-Sheng Chen

Medical Centers

  • St. Johns University, New York, NY.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Thyroid Cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • ATP Binding Cassette Transporter B1

  • Kinase Insert Domain Receptor

Drug/Treatment

  • Cabozantinib

  • Mitoxantrone

  • Paclitaxel

  • Topotecan Hydrochloride

  • L-Tyrosine

  • SN38

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved